DNM1L and Parkinson disease: Furthermore, nitrosylation of caveolin is implicated in the breakdown of the outer blood–retinal barrier in diabetes [47], and that of Drp1 is observed in several neurodegenerative diseases, including Parkinson’s disease and Huntington’s disease [48,49].